180 related articles for article (PubMed ID: 37814094)
21. Prevalence and risk factors of low bone mineral density in juvenile onset ankylosing spondylitis.
Bao J; Chen Y; Bao YX
Calcif Tissue Int; 2014 Aug; 95(2):108-11. PubMed ID: 24854154
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis.
Donnelly S; Doyle DV; Denton A; Rolfe I; McCloskey EV; Spector TD
Ann Rheum Dis; 1994 Feb; 53(2):117-21. PubMed ID: 8129456
[TBL] [Abstract][Full Text] [Related]
23. Factors relating to bone mineral density in young and middle-aged patients with ankylosing spondylitis.
Wu X; Zhong JY; Wang G; Xu HJ
Chin Med J (Engl); 2021 Oct; 134(21):2556-2563. PubMed ID: 34653076
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis.
Beek KJ; Rusman T; van der Weijden MAC; Lems WF; van Denderen JC; Konsta M; Visman I; Nurmohamed MT; van der Horst-Bruinsma IE
J Bone Miner Res; 2019 Jun; 34(6):1041-1048. PubMed ID: 30690799
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases.
Wang DM; Zeng QY; Chen SB; Gong Y; Hou ZD; Xiao ZY
Clin Exp Rheumatol; 2015; 33(4):465-70. PubMed ID: 25962324
[TBL] [Abstract][Full Text] [Related]
26. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes?
Kaya A; Ozgocmen S; Kamanli A; Ardicoglu O
Med Princ Pract; 2009; 18(6):470-6. PubMed ID: 19797924
[TBL] [Abstract][Full Text] [Related]
27. A Correlation Analysis Between Adult Hepatic Fibrosis and Bone Mineral Density of the Lumbar Spine and Hip.
Chen C; Zhang R; Ren C; Wang Y
Altern Ther Health Med; 2024 Jan; 30(1):172-178. PubMed ID: 37773670
[TBL] [Abstract][Full Text] [Related]
28. Trabecular Bone Score (TBS) Predicts Fracture in Ankylosing Spondylitis: The Manitoba BMD Registry.
Richards C; Hans D; Leslie WD
J Clin Densitom; 2020; 23(4):543-548. PubMed ID: 32094033
[TBL] [Abstract][Full Text] [Related]
29. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures.
Malochet-Guinamand S; Pereira B; Tatar Z; Tournadre A; Moltó A; Dougados M; Soubrier M
BMC Musculoskelet Disord; 2017 Aug; 18(1):357. PubMed ID: 28830392
[TBL] [Abstract][Full Text] [Related]
31. Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis.
Haroon NN; Sriganthan J; Al Ghanim N; Inman RD; Cheung AM
Semin Arthritis Rheum; 2014 Oct; 44(2):155-61. PubMed ID: 24909809
[TBL] [Abstract][Full Text] [Related]
32. How should clinicians manage osteoporosis in ankylosing spondylitis?
Bessant R; Keat A
J Rheumatol; 2002 Jul; 29(7):1511-9. PubMed ID: 12136913
[TBL] [Abstract][Full Text] [Related]
33. Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies.
van der Weijden MA; van Denderen JC; Lems WF; Heymans MW; Dijkmans BA; van der Horst-Bruinsma IE
Clin Rheumatol; 2011 Apr; 30(4):497-503. PubMed ID: 20697764
[TBL] [Abstract][Full Text] [Related]
34. Preoperative bone health assessment and optimization in spine surgery.
Anderson PA; Kadri A; Hare KJ; Binkley N
Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis.
Ghozlani I; Ghazi M; Nouijai A; Mounach A; Rezqi A; Achemlal L; Bezza A; El Maghraoui A
Bone; 2009 May; 44(5):772-6. PubMed ID: 19442629
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
37. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis.
Toussirot E; Michel F; Wendling D
Rheumatology (Oxford); 2001 Aug; 40(8):882-8. PubMed ID: 11511757
[TBL] [Abstract][Full Text] [Related]
38. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
Kim HR; Lee SH; Kim HY
Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
[TBL] [Abstract][Full Text] [Related]
39. Bone and stone in ankylosing spondylitis: osteoporosis and urolithiasis.
Incel NA; Gökoğlu F; Nacir B; Incel N
Clin Rheumatol; 2006 Sep; 25(5):667-70. PubMed ID: 16333564
[TBL] [Abstract][Full Text] [Related]
40. Opportunistic computed tomography screening shows a high incidence of osteoporosis in ankylosing spondylitis patients with acute vertebral fractures.
Emohare O; Cagan A; Polly DW; Gertner E
J Clin Densitom; 2015; 18(1):17-21. PubMed ID: 25172008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
